Source: Google NewsPublished on 2021-02-22
Related Articles:
- Monthly Research Review – November 2020 November 30, 2020 At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
- To Vaccinate U.S. Veterans, Health Care Workers Must Cross Mountains, Plains and Tundra February 18, 2021 A Learjet 31 took off before daybreak from Helena Regional Airport in Montana in late January, carrying six Veterans Affairs medical providers and 250 doses of historic cargo cradled in a plug-in cooler designed to minimize breakage. Even in a state where 80-mph speed limits are normal, ground transportation across long distances is risky for the Moderna mRNA-1273 vaccine, which…
- Effective Immediately: Utahns Ages 16+ With Certain Health Conditions Can Get Vaccine - ksltv.com February 25, 2021 Effective Immediately: Utahns Ages 16+ With Certain Health Conditions Can Get Vaccine ksltv.com
- State prepares to offer vaccine to Utahns 18+ with medical conditions - KSL.com February 23, 2021 State prepares to offer vaccine to Utahns 18+ with medical conditions KSL.com
- The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
- Who’s Eligible To Get The COVID-19 Vaccine In Utah? - ksltv.com February 25, 2021 Who’s Eligible To Get The COVID-19 Vaccine In Utah? ksltv.com
- I have Parkinson’s. Should I get a COVID vaccine? February 7, 2021 With several COVID-19 vaccines now approved for emergency use, you and your loved ones may have questions about the vaccine and its safety and efficacy for people with Parkinson’s. Be sure to address any questions and concerns with your doctor, and catch up on the latest research and reports about COVID vaccines and Parkinson’s by exploring these resources. COVID-19 Vaccination…
- COVID-19 and Parkinson’s February 12, 2021 Parkinson Canada is dedicated to the health and wellbeing of all people living with Parkinson’s. We continue to closely monitor information on the COVID-19 pandemic provided by the Public Health Agency of Canada and other public health authorities. What we know today is that the distribution of vaccines is rolling out across Canada in a phased approach that prioritizes access…
- Parkinson’s, Flu Shots & You October 11, 2019 October signals the beginning of influenza season, a time when many wonder, “Should I get a flu shot?”. The short answer is, yes, but for people living with Parkinson’s, there can be additional concerns or questions. Let’s take a look at what you and your care team can do to prepare for the 2019-2020 flu season. Who Should Get a…
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. December 12, 2020 Related ArticlesSafety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2020 Dec 08;: Authors: Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, Bibi S, Briner C, Cicconi P, Collins AM,…
- UNS’ Investigational Vaccine UB-312 Holds Potential to Prevent Parkinson’s, Other Neurological Diseases, Data Show November 16, 2018 An investigational vaccine being developed by United Neuroscience (UNS) presented several advantages over traditional vaccines to treat progressive disorders, such as Parkinson’s disease, according to preclinical data. The vaccine, called UB-312, was more selective to prevent toxic aggregates of alpha-synuclein in mouse models of the disease. These latest findings were discussed during the Parkinson’s UK Research Conference 2018 held in York, England. The…
- The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
- Parkinson’s Vaccine Triggers Solid Immune Response, Phase 1 Clinical Trial Shows June 15, 2017 AFFiRiS’s new Parkinson’s vaccine, AFFITOPE PD03A, triggered a solid immune response against the alpha-Synuclein (aSyn) protein associated with the disease, according to a Phase 1 clinical trial. Patients also tolerated the therapy well, researchers said. Werner Poewe, a professor at Austria’s Medical University Insbruck, presented the results at the 21stInternational Congress of Parkinson’s Disease and Movement Disorders in Vancouver, Canada, June 4-8. He is part of…
- Will Utahns wait their turn in line once vaccines open up for those with underlying conditions? - Salt Lake Tribune February 28, 2021 Will Utahns wait their turn in line once vaccines open up for those with underlying conditions? Salt Lake Tribune
- Noteworthy Utahns who died in 2020: Judges, advocates, artists, athletes, coaches, trailblazers - Salt Lake Tribune December 29, 2020 Noteworthy Utahns who died in 2020: Judges, advocates, artists, athletes, coaches, trailblazers Salt Lake Tribune
- Is a vaccine for Parkinson’s disease possible? November 3, 2020 As the world awaits an effective vaccine for SARS-CoV2 (the virus that causes COVID-19), vaccines and vaccination are at the front and center of the news and in our minds. A vaccine is a substance that is introduced into the body in order to stimulate the immune system to provide protection against a particular disease. Did you know that many…
- Is a vaccine for Parkinson’s disease possible? November 3, 2020 As the world awaits an effective vaccine for SARS-CoV2 (the virus that causes COVID-19), vaccines and vaccination are at the front and center of the news and in our minds. A vaccine is a substance that is introduced into the body in order to stimulate the immune system to provide protection against a particular disease. Did you know that many…
- Utahns age 16 and older with certain health conditions can make vaccine appointments now, Gov. Cox says - Salt Lake Tribune February 25, 2021 Utahns age 16 and older with certain health conditions can make vaccine appointments now, Gov. Cox says Salt Lake Tribune
- FDA Response Bolsters Affiris’ Plans for Potential Parkinson’s Vaccine Affitope January 29, 2020 The U.S. Food and Drug Administration (FDA) has responded to Affiris‘ pre-investigational new drug (IND) submission regarding a planned Phase 2 clinical trial of the potential Parkinson’s vaccine Affitope (PD01A). After reviewing previous preclinical and clinical data, the FDA answered questions posed by the company and provided guidance related to designing the upcoming trial. Based on that response, Affiris intends to…
- Vaccine breakthrough November 10, 2020 Tuesday 10 November 2020Vaccines are hard to develop. They typically take 10-15 years to bring to market at huge cost and effort. Despite their widespread use, there is still only one disease to have been vaccinated off the face of the Earth. Smallpox was the first disease to be vaccinated against, famously by English country doctor Edward Jenner experimenting on…
- Affiris Announces Phase 2 Study of Potential Parkinson’s Vaccine January 14, 2020 Affiris is preparing for a Phase 2 clinical trial to test Affitope (PD01A), an experimental medicine that, if successful, could lead to a vaccine against Parkinson’s disease. Affitope triggers the production of antibodies — molecules that recognize specific targets — against alpha-synuclein, a protein found in the brain that may be involved in transmitting information between neurons. While its precise function remains…
- The basket case February 10, 2021 # # # # One of the more interesting pieces of clinical trial news in 2020 was the publication of the results of a “basket study” for neurological conditions. This was a trial that involved a drug being tested on a selection of neurodegenerative conditions, rather than just one condition. Between December 2013 to May 2017, researchers recruited a total…